🚀 VC round data is live in beta, check it out!
Wuxi AppTec Valuation Multiples
Discover revenue and EBITDA valuation multiples for Wuxi AppTec and similar public comparables like IDEXX Laboratories, Lonza Group, Samsung BioLogics, Agilent and more.
Wuxi AppTec Overview
About Wuxi AppTec
Wuxi AppTec Co Ltd provides a portfolio of research and manufacturing services throughout the discovery, development, and manufacturing spectrum for small molecule drugs, development of computer software and databases as well as consulting services for combinatorial chemistry and pharmaceuticals. The services offered by the company include drug research and development testing, clinical research services, an end-to-end CRDMO platform for peptide, oligonucleotide, and small molecules, and integrated biology services and solutions for drug discovery. The company's reportable segments are WuXi Chemistry, which derives maximum revenue, WuXi Testing, WuXi Biology, and Others. Geographically, it derives key revenue from the United States of America, followed by China, Europe, and other regions.
Founded
2000
HQ
Employees
39.4K
Website
Financials (LTM)
EV
$39B
Wuxi AppTec Financials
Wuxi AppTec reported last 12-month revenue of $7B and EBITDA of $3B.
In the same LTM period, Wuxi AppTec generated $3B in gross profit, $3B in EBITDA, and $3B in net income.
Revenue (LTM)
Wuxi AppTec P&L
In the most recent fiscal year, Wuxi AppTec reported revenue of $7B and EBITDA of $4B.
Wuxi AppTec expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $7B | XXX | $7B | XXX | XXX | XXX |
| Gross Profit | $3B | XXX | $3B | XXX | XXX | XXX |
| Gross Margin | 48% | XXX | 48% | XXX | XXX | XXX |
| EBITDA | $3B | XXX | $4B | XXX | XXX | XXX |
| EBITDA Margin | 50% | XXX | 61% | XXX | XXX | XXX |
| EBIT Margin | 43% | XXX | 45% | XXX | XXX | XXX |
| Net Profit | $3B | XXX | $3B | XXX | XXX | XXX |
| Net Margin | 39% | XXX | 42% | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Wuxi AppTec Stock Performance
Wuxi AppTec has current market cap of $44B, and enterprise value of $39B.
Market Cap Evolution
Wuxi AppTec's stock price is $14.76.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $39B | $44B | -6.0% | XXX | XXX | XXX | $0.94 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialWuxi AppTec Valuation Multiples
Wuxi AppTec trades at 5.7x EV/Revenue multiple, and 11.4x EV/EBITDA.
EV / Revenue (LTM)
Wuxi AppTec Financial Valuation Multiples
As of April 19, 2026, Wuxi AppTec has market cap of $44B and EV of $39B.
Equity research analysts estimate Wuxi AppTec's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Wuxi AppTec has a P/E ratio of 16.3x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $44B | XXX | $44B | XXX | XXX | XXX |
| EV (current) | $39B | XXX | $39B | XXX | XXX | XXX |
| EV/Revenue | 5.7x | XXX | 5.9x | XXX | XXX | XXX |
| EV/EBITDA | 11.4x | XXX | 9.7x | XXX | XXX | XXX |
| EV/EBIT | 13.1x | XXX | 13.1x | XXX | XXX | XXX |
| EV/Gross Profit | 11.8x | XXX | 12.4x | XXX | XXX | XXX |
| P/E | 16.3x | XXX | 15.7x | XXX | XXX | XXX |
| EV/FCF | 20.6x | XXX | 23.0x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Wuxi AppTec Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Wuxi AppTec Margins & Growth Rates
Wuxi AppTec's revenue in the last 12 month grew by 16%.
Wuxi AppTec's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.0M for the same period.
Wuxi AppTec's rule of 40 is 60% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Wuxi AppTec's rule of X is 83% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Wuxi AppTec Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 16% | XXX | 15% | XXX | XXX | XXX |
| EBITDA Margin | 50% | XXX | 61% | XXX | XXX | XXX |
| EBITDA Growth | 4% | XXX | (16%) | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 60% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 83% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.2M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.0M | XXX | XXX | XXX |
| S&M Expenses to Revenue | 2% | XXX | 2% | XXX | XXX | XXX |
| G&A Expenses to Revenue | 6% | XXX | 6% | XXX | XXX | XXX |
| R&D Expenses to Revenue | 2% | XXX | 2% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 10% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Wuxi AppTec Public Comps
See public comps and valuation multiples for other Contract Research & Manufacturing and Laboratory Services comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Wuxi AppTec | XXX | XXX | XXX | XXX | XXX | XXX |
| IDEXX Laboratories | XXX | XXX | XXX | XXX | XXX | XXX |
| Lonza Group | XXX | XXX | XXX | XXX | XXX | XXX |
| Samsung BioLogics | XXX | XXX | XXX | XXX | XXX | XXX |
| Agilent | XXX | XXX | XXX | XXX | XXX | XXX |
| Waters | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Wuxi AppTec M&A Activity
Wuxi AppTec acquired XXX companies to date.
Last acquisition by Wuxi AppTec was on XXXXXXXX, XXXXX. Wuxi AppTec acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Wuxi AppTec
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialWuxi AppTec Investment Activity
Wuxi AppTec invested in XXX companies to date.
Wuxi AppTec made its latest investment on XXXXXXXX, XXXXX. Wuxi AppTec invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Wuxi AppTec
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Wuxi AppTec
| When was Wuxi AppTec founded? | Wuxi AppTec was founded in 2000. |
| Where is Wuxi AppTec headquartered? | Wuxi AppTec is headquartered in China. |
| How many employees does Wuxi AppTec have? | As of today, Wuxi AppTec has over 39K employees. |
| Who is the CEO of Wuxi AppTec? | Wuxi AppTec's CEO is Steve Qing Yang. |
| Is Wuxi AppTec publicly listed? | Yes, Wuxi AppTec is a public company listed on Shanghai Stock Exchange. |
| What is the stock symbol of Wuxi AppTec? | Wuxi AppTec trades under 603259 ticker. |
| When did Wuxi AppTec go public? | Wuxi AppTec went public in 2018. |
| Who are competitors of Wuxi AppTec? | Wuxi AppTec main competitors are IDEXX Laboratories, Lonza Group, Samsung BioLogics, Agilent. |
| What is the current market cap of Wuxi AppTec? | Wuxi AppTec's current market cap is $44B. |
| What is the current revenue of Wuxi AppTec? | Wuxi AppTec's last 12 months revenue is $7B. |
| What is the current revenue growth of Wuxi AppTec? | Wuxi AppTec revenue growth (NTM/LTM) is 16%. |
| What is the current EV/Revenue multiple of Wuxi AppTec? | Current revenue multiple of Wuxi AppTec is 5.7x. |
| Is Wuxi AppTec profitable? | Yes, Wuxi AppTec is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Wuxi AppTec? | Wuxi AppTec's last 12 months EBITDA is $3B. |
| What is Wuxi AppTec's EBITDA margin? | Wuxi AppTec's last 12 months EBITDA margin is 50%. |
| What is the current EV/EBITDA multiple of Wuxi AppTec? | Current EBITDA multiple of Wuxi AppTec is 11.4x. |
| What is the current FCF of Wuxi AppTec? | Wuxi AppTec's last 12 months FCF is $2B. |
| What is Wuxi AppTec's FCF margin? | Wuxi AppTec's last 12 months FCF margin is 28%. |
| What is the current EV/FCF multiple of Wuxi AppTec? | Current FCF multiple of Wuxi AppTec is 20.6x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.